2.23

0.90% 0.02

After Hours: 2.21 -0.02 -0.90%

Vivos Therapeutics Inc (VVOS)

Overview News Price History Financials Discussions Forecast Stock Split

Vivos Therapeutics Inc stock is traded at $2.23, with a volume of 52,171. It is up +0.90% in the last 24 hours and down -13.23% over the past month. Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Previous Close:

$2.21

Open:

$2.25

24h Volume:

52,171

Relative Volume:

0.55

Market Cap:

$14.25M

Revenue:

$14.58M

Net Income/Loss:

$-12.57M

P/E Ratio:

-0.3926

EPS:

-5.68

Net Cash Flow:

$-13.07M

1W Performance:

-7.85%

1M Performance:

-13.23%

6M Performance:

-46.52%

1Y Performance:

-3.04%

1-Day Range:

$2.16

$2.32

1-Week Range:

$2.16

$2.47

52-Week Range:

$1.97

$6.28

Vivos Therapeutics Inc Stock (VVOS) Company Profile

Name

Vivos Therapeutics Inc

Sector

Healthcare (1170)

Industry

Medical Devices (157)

Phone

(866)908-4867

Address

7921 SOUTHPARK PLAZA,, LITTLETON

Employee

109

Twitter

Next Earnings Date

2025-03-31

Latest SEC Filings

VVOS's Discussions on Twitter

Compare VVOS with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
VVOS Vivos Therapeutics Inc	2.23	14.25M	14.58M	-12.57M	-13.07M	-5.68
ABT Abbott Laboratories	133.58	232.41B	42.34B	13.50B	6.66B	7.71
BSX Boston Scientific Corp	102.09	155.73B	17.55B	2.03B	2.72B	1.37
SYK Stryker Corp	383.89	146.23B	23.22B	2.86B	3.58B	7.40
MDT Medtronic Plc	87.44	106.37B	33.54B	4.66B	5.19B	3.62
EW Edwards Lifesciences Corp	77.52	45.88B	5.54B	4.18B	623.10M	7.00

Vivos Therapeutics Inc Stock (VVOS) Latest News

01:23 AM

vivos therapeutics appoints baker tilly as new auditor following merger - Investing.com Australia

01:23 AM

Jun 06, 2025

vivos therapeutics appoints baker tilly as new auditor following merger By Investing.com - Investing.com South Africa

Jun 06, 2025

Jun 04, 2025

Vivos Therapeutics, Inc. (NASDAQ:VVOS) Sees Large Drop in Short Interest - Defense World

Jun 04, 2025

May 30, 2025

Sleep Apnea Oral Appliances MarketGlobal Forecast to - GlobeNewswire

May 30, 2025

May 25, 2025

Vivos Therapeutics (NASDAQ:VVOS) Cut to Sell at Wall Street Zen - Defense World

May 25, 2025

May 23, 2025

Vivos Therapeutics (NASDAQ:VVOS) Stock Rating Lowered by Alliance Global Partners - Defense World

May 23, 2025

Vivos Therapeutics (NASDAQ:VVOS) Cut to “Hold” at Alliance Global Partners - Defense World

May 23, 2025

May 22, 2025

Vivos Therapeutics signals transformative growth with SCN acquisition and expects positive cash flow by end of 2025 - MSN

May 22, 2025

May 20, 2025

Vivos Therapeutics (VVOS) Downgraded Amidst Business Model Challenges | VVOS Stock News - GuruFocus

May 20, 2025

Vivos Therapeutics (VVOS) Downgraded Amidst Business Model Chall - GuruFocus

May 20, 2025

May 18, 2025

Why Vivos Therapeutics (VVOS) Stock Is Down 25% Today - MSN

May 18, 2025

May 16, 2025

Vivos Therapeutics’ Earnings Call: Strategic Shifts Amid Financial Challenges - TipRanks

May 16, 2025

Vivos Therapeutics Reports First Quarter 2025 Financial Results and Provides Operational Update - The Manila Times

May 16, 2025

Vivos Therapeutics Shifts Strategy Amid Financial Results - TipRanks

May 16, 2025

May 15, 2025

Earnings call transcript: Vivos Therapeutics reports Q1 2025 earnings, stock rises - Investing.com Nigeria

May 15, 2025